Preparation and characterization of Simvastatin solid dispersion using skimmed milk

Drug Development and Industrial Pharmacy

Volumn 41, Issue 1, 2015, Pages 22-27

  Sonar, P A ^a   Behera, A L ^a   Banerjee, S K ^a   Gaikwad, D D ^a   Harer, S L ^b  

^a Vishal Institute of Pharmaceutical Education and Research   (India)

^b Sharadchandra Pawar College of Pharmacy   (India)

Author keywords

Bioavailability; Dissolution; Simvastatin; Skimmed milk; Solid dispersion; Solubility; Triton induced hyperlipidemia

Indexed keywords

SIMVASTATIN; TYLOXAPOL;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; FREEZE DRYING; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MILK; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SOLUBILITY; SYNTHESIS; X RAY DIFFRACTION;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ELECTRON, SCANNING; MILK; SIMVASTATIN; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84918777262     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.845836     Document Type: Article

References (39)

1. Verma S, Rawat A, Kaul M, Saini S. Solid dispersion: a strategy for solubility enhancement. Int J Pharm Tech 2011;3:1062-99.
2. van de Waterbeemd H. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. Eur J Pharm Sci 1998;7:1-3.
3. Choudhary A, Aggarwal G, Zakir F, Kumar V. Mini review: journey of solid dispersion technique from bench to scale. Int Res J Pharm 2011;2:46-51.
4. Sekiguchi K, Obi N. Studies on absorption of eutectic mixtures. I. A comparison of behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem Pharm Bull 1961; 9:866-72.
5. Shah TJ, Amin AF, Parikh JR, Parikh RH. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech 2007;8:18-24.
6. Bikiaris DN. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 2011;8:1501-19.
7. Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of Simvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metab Dispos 2006;34:175-81.
8. Shete G, Puri V, Kumar L, Bansal AK. Solid state characterization of commercial crystalline and amorphous Simvastatin calcium samples. AAPS Pharm Sci Tech 2010;11:598-609.
9. Ahjel SW, Lupuleasa D. Enhancement of solubility and dissolution rate of different forms of Simvastatin calcium in direct compression tablet formulas. Farmacia 2009;3:291-300.
10. Palem CR, Patel S, Pokharkar VB. Solubility and stability enhancement of Simvastatin by cyclodextrin complexation PDA. J Pharm Sci Technol 2009;63:217-25.
11. Anwar M, Warsi MH, Mallick N, et al. Enhanced bioavailability of nano-sized chitosan-Simvastatin conjugate after oral administration to rats. Eur J Pharm Sci 2011;44:241-9.
12. Bobe KR, Subrahmanya CR, Suresh S, et al. Formulation and evaluation of solid dispersion of Simvastatin with various carriers. Int J Compr Pharm 2011;1:1-6.
13. Girones MA, Roan JR, de la Hoz B, Sanchez Cano M. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol Immunopathol (Madr) 2008;36:110-12.
14. Shelanski HA. PVP K-30 14C single dose excretion study. Unpublished report from the Industrial Toxicology Laboratories, United States of America. Submitted to the World Health Organization by BASF; 1953.
15. Shelanski MV. Final two-year report of a chronic oral toxicity study with PVP (K-30) in rats. Unpublished report from the Industrial Biological Research and Testing Laboratories, United States of America. Submitted to the World Health Organization by BASF; 1957.
16. Sahin NO, Arslan H. Inclusion complex of prednisolone with skimmed milk. Part I: physicochemical characterization. Yakugaku Zasshi 2007;127:1255-61.
17. Topaloglu Y, Yener G, Kavalali G Investigations of antiinflammatory activity of solid dispersion of indomethacin prepared with skimmed milk. Acta Pharm Turcica 1998;40:13-16.
18. Vippagunta SR, Maul KA, Tallavajhala S. Grant D J Solid state characterization of nifedipine solid dispersions. Int J Pharm 2002; 236:111-23.
19. Chowdary KP, Rao SS. Investigation of dissolution enhancement of itraconazole in superdisintegrants. Drug Dev Ind Pharm 2000;26: 1217-20.
20. Venkates K, Arunkumar N, Verma PRP, Rani C. Preparation and in-vitro characterization of valsartan solid dispersions using skimmed milk powder as carrier. Int J Pharm Tech Res 2009;3: 431-7.
21. Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilization of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K 25. Eur J Pharm Sci 2001;12:261-9.
22. Hecq J, Deleers M, Fanara D, et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005;299:167-77.
23. Rao M, Mandage Y, Thanki K, Bhise S. Dissolution improvement of Simvastatin by surface solid dispersion technology. Dissolution Technol 2010;1:27-34.
24. Topaloglu Y, Yener G, Gönüllü U. Inclusion of ketoprofen with skimmed milk by freeze-drying. Farmaco 1999;54:648-52.
25. Arunkumar N, Deecaraman M, Rani C, et al. Preparation and solid state characterization of Simvastatin nanosuspensions for enhanced solubility and dissolution. Int J Pharm Tech Res 2009;1:1725-30.
26. Serajuddin AT. Solid dispersions of poorly-water soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058-66.
27. Frantz ID, Hinkelman BT. Acceleration of hepatic cholesterol synthesis by triton WR-1339. J Exp Med 1955;101:225-32.
28. Kadu PJ, Kushare SS, Thacker DD, Gattani SG. Enhancement of oral bioavailability of Simvastatin calcium by self-emulsifying drug delivery systems. Pharm Dev Technol 2011;16:65-74.
29. Vijaya Kumar SG, Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi 2006;126:93-7.
30. Ahire BR, Rane BR, Bakliwal SR, Pawar SP. Solubility enhancement of poorly water soluble drug by solid dispersion techniques. Int J Pharm Tech Res 2010;2:2007-15.
31. Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole co-precipitates. J Pharm Sci 1969;58:538-49.
32. Patel M, Tekade A, Gattani S, Surana S. Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS Pharm Sci Tech 2008;9:1262-9.
33. Srikanth MV, Rao NS, Sunil SA, et al. Statistical design and evaluation of propranolol HCl gastric floating tablet. Acta Pharm Sin B 2012;2:60-9.
34. Zidan AS, Rahman Z, Sayeed V, et al. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis. Int J Pharm 2012;423:341-50.
35. Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. J Pharm Sci 2012;101:1355-77.
36. Biradar SS, Patil PA. Protective effect of Bauhinia variegata extracts on triton induced hyperlipidemia in rats. J Cell Tissue Res 2011;11: 2785-8.
37. Chen TY, Pan BS. Ex vivo inhibitory effect on tilapia LDL oxidation and hypolipidemia properties of Glycine tomentella root extract. Comp Biochem Physiol A Mol Integr Physiol 2007;148: 189-95.
38. Bruemmer D, Yin F, Liu J, et al. Simvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells. Eur J Pharmacol 2003;462:15-23.
39. Kleemann R, Verschuren L, de Rooij BJ, et al. Evidence for anti-inflammatory activity of statins and PPAR alpha activators in human C-reactive protein transgenic mice in-vivo and in cultured human hepatocytes in-vitro. Blood 2004;103:4188-94.